Booster dose is available to all residents aged 18+ and can be applied six months after the second dose of any other vaccine administered in UAE
The company has has 10 existing labs in India
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs
The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
Featuring identity verification using artificial intelligence (AI), LabPort was designed to facilitate immediate results reporting for diagnostic testing even in high-volume, field-based testing environments
Cryo-technology helps in early diagnosis and palliative care in later stages of cancer
While industry steps out of its comfort zone to innovate, the government has to support by allocating funds across research lifecycle and offer incentives for innovation
Obseva announced previously that the company has entered into a partnership with Syneos Health to support commercialization of linzagolix in the US and EU
Subscribe To Our Newsletter & Stay Updated
